Sandip Lal - Bharat Immunologicals Insider

Company Secretary and Member of Share Transfer and Shareholders'/Investors' Grievance Committee

We currently do not have informatin regarding Sandip Lal. This executive tanure with Bharat Immunologicals Biologicals Corp Ltd is not currenlty determined.
        
91 57 3223 8758  http://www.bibcol.com

Management Efficiency

The company has return on total asset (ROA) of (1.69) % which means that it has lost $1.69 on every $100 spent on asset. This is way below average.
The company has accumulated 177.56 M in total debt with debt to equity ratio (D/E) of 0.5 which is about average as compared to similar companies. Bharat Immunologicals Biologicals Corp Ltd has Current Ratio of 1.66 which is within standard range for the sector.

Entity Summary

Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals solutions in India. Bharat Immunologicals Biologicals Corp Ltd (BIBCL) is traded on Bombay Stock Exchange in India. It is located in Bulandshahr, and employs 5 people.

Did you try this?

Run Equity Analysis Now
   

Equity Analysis

Research over 250,000 global equities including funds, stocks and etfs to find investment opportunities
Hide  View All  Next  Launch Equity Analysis
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Bharat Immunologicals Biologicals Corp Ltd to your portfolio

Top Management

Bharat Immunologicals Leadership Team
U Singh, CFO
C Benjwal, VP
Sunil Sharma, Executive
Mrs Bhatia, Managing Director
Sandip Lal, Executive
Sreeshan Raghavan, Chairman
Indrajit Singh, Executive
M Bhatia, Managing Director

Stock Performance

Bharat Immunologicals Performance Indicators